Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | KCTD12 |
| Upstream (Parents) |
|---|
| (<<) AKT3 → KCTD12 |
| (<<) CAV1 → KCTD12 |
| (<<) CLEC2B → KCTD12 |
| (<<) EFEMP1 → KCTD12 |
| (<<) EFEMP2 → KCTD12 |
| (<<) GNG11 → KCTD12 |
| (<<) GPNMB → KCTD12 |
| (<<) IL1R1 → KCTD12 |
| (<<) MMP2 → KCTD12 |
| (<<) MXRA8 → KCTD12 |
| (<<) NR3C1 → KCTD12 |
| (<<) SGK1 → KCTD12 |
| (<<) SYNPO → KCTD12 |
| (<<) VIM → KCTD12 |
| Downstream (Children) |
|---|
| KCTD12 → ADCY7 (>>) |
| KCTD12 → ANTXR1 (>>) |
| KCTD12 → CASP1 (>>) |
| KCTD12 → CBFA2T3 (>>) |
| KCTD12 → CCDC88A (>>) |
| KCTD12 → CSGALNACT2 (>>) |
| KCTD12 → CYB5R3 (>>) |
| KCTD12 → FOXA2 (>>) |
| KCTD12 → GBP2 (>>) |
| KCTD12 → GPX2 (>>) |
| KCTD12 → GYPC (>>) |
| KCTD12 → HDAC9 (>>) |
| KCTD12 → HIF1A (>>) |
| KCTD12 → HLA-DOA (>>) |
| KCTD12 → IGFBP7 (>>) |
| KCTD12 → KLF2 (>>) |
| KCTD12 → LCP1 (>>) |
| KCTD12 → LRP5 (>>) |
| KCTD12 → MAL (>>) |
| KCTD12 → MMP15 (>>) |
| KCTD12 → MSN (>>) |
| KCTD12 → OGFR (>>) |
| KCTD12 → PIK3CD (>>) |
| KCTD12 → PIK3CG (>>) |
| KCTD12 → PIP4K2A (>>) |
| KCTD12 → PPP3CB (>>) |
| KCTD12 → PRKCA (>>) |
| KCTD12 → PRNP (>>) |
| KCTD12 → RPS6KA2 (>>) |
| KCTD12 → SALL2 (>>) |
| KCTD12 → SOX17 (>>) |
| KCTD12 → TCF4 (>>) |
| KCTD12 → TIMP2 (>>) |
| KCTD12 → TUBA1A (>>) |
| KCTD12 → VAV1 (>>) |
| KCTD12 → ZNF365 (>>) |
